Neurona Therapeutics
Neurona Therapeutics is a pre-clinical stage biotechnology company that was founded by four neuroscientists and stem cell pioneers at The University of California, San Francisco. They are focused on the discovery and development of cell-based therapies to treat intractable neurological disease. Its initial aim is to generate therapeutic compositions of a specific type of nerve cell (or neuron) for targeted delivery into the injured nervous system. Based on nearly two decades of research, they believe that particular subpopulations of neurons have the unique ability to integrate and repair dysregulated neural circuits. Its talented team of scientists, scientific advisors, and board directors is working to accelerate breakthrough treatments for patients with significant unmet medical needs.
Domain
neuronatherapeutics.com
Country
United StatesIndustry
BiotechnologyEmployees
101-250
Last Funding
$14.0M
Founded
2008
Tech Stack (5 technologies)
Frequently Asked Questions
What technologies does Neurona Therapeutics use?+
Neurona Therapeutics uses 5 technologies including CookieYes, Google Hosted Libraries, jQuery.
What industry is Neurona Therapeutics in?+
Neurona Therapeutics operates in the Biotechnology industry.
Where is Neurona Therapeutics based?+
Neurona Therapeutics is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026